| Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy (NCT01624480) | Teva Branded Pharmaceutical Products R&D, Inc. | 2012-07-01 |
| A Study of Intermittent, High-dose Afatinib to Determine the Maximal Tolerated Dose and Assess Activity of This Dose Against Non-small Cell Lung Cancer With T790M Mutations (NCT01647711) | Boehringer Ingelheim | 2012-07-01 |
| Chronic Moderate Sleep Restriction in Older Adults (NCT01642719) | University of California, Los Angeles | 2012-07-01 |
| Physiological Study to Determine the Allergic Skin Activity After Different Skin Preparation (NCT01628484) | University of Zurich | 2012-07-01 |
| Single Ascending Dose Study of RBP-6000 (NCT03002961) | Indivior Inc. | 2012-07-01 |
| A Trial of Cabozantinib (XL184) and Gemcitabine in Advanced Pancreatic Cancer (NCT01663272) | University of Michigan Rogel Cancer Center | 2012-07-01 |
| Efficacy of Sildenafil in the Improvement of Cognition and Quality of Life in Patients With Cirrhosis of Liver. A Proof of Concept Study. (NCT02028429) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2012-07-01 |
| Safety of Hyaluronan Thiomer i.o. Implant During Combined Phacoemulsification - Non Penetrating Deep Sclerectomy (NCT01887873) | Croma-Pharma GmbH | 2012-07-01 |
| A Stage 2 Cognitive-behavioral Trial: Reduce Alcohol First in Kenya Intervention (NCT01503255) | Brown University | 2012-07-01 |
| Quercetin in Children With Fanconi Anemia; a Pilot Study (NCT01720147) | Children's Hospital Medical Center, Cincinnati | 2012-07-01 |
| Near Infrared Fluorescent Imaging in Thyroid and Parathyroid Surgery With the Fluobeam(TM) System of Fluoptics (NCT01598727) | Sheffield Teaching Hospitals NHS Foundation Trust | 2012-07-01 |
| Safety and Efficacy of Cannabidiol for Grade I/II Acute Graft Versus Host Disease (GVHD) After Allogeneic Stem Cell Transplantation (NCT01596075) | Rabin Medical Center | 2012-07-01 |
| A Study to Assess Safety, Tolerability and Pharmacokinetics of Ceftaroline in Healthy Subjects (NCT01612507) | Pfizer | 2012-07-01 |
| Bortezomib in Patients With Chronic Graft Versus Host Disease (NCT01672229) | Mehrdad Abedi, MD | 2012-07-01 |
| Transfer of Genetically Engineered Lymphocytes in Melanoma Patients (NCT01586403) | Loyola University | 2012-07-01 |
| Photodynamic Therapy (PDT) With Temoporfin for Non-Resectable Non-Small-Cell Lung Cancer (NCT01637376) | University of Arkansas | 2012-07-01 |
| Persistence-Targeted Smoking Cessation (NCT01654107) | Rutgers, The State University of New Jersey | 2012-07-01 |
| Leflunomide+Vemurafenib in V600 Mutant Met. Melanoma (NCT01611675) | Massachusetts General Hospital | 2012-07-01 |
| Effect of Oxytocin Nasal Sprays on Social Behavior in Social Anxiety Disorder (NCT01856530) | Stefan G. Hofmann | 2012-07-01 |
| IR-guided Ablation (IRGA) Combined With Stereotactic Ablative Radiation (SABR) for Large Lung Tumors (NCT01746810) | New Mexico Cancer Research Alliance | 2012-07-01 |
| Study of Tabalumab (LY2127399) in Japanese Participants With Relapsed or Refactory Multiple Myeloma (NCT01556438) | Eli Lilly and Company | 2012-07-01 |
| [18F]Fluciclatide-PET, Pazopanib and Paclitaxel in Ovarian Cancer (NCT01608009) | Imperial College London | 2012-07-01 |
| ErbB2 Positive Metastatic Breast Cancer (NCT01658358) | China Medical University Hospital | 2012-07-01 |
| A Study to Evaluate the Effects of Domperidone on Cardiac Repolarization in Healthy Volunteers (NCT01643889) | Janssen Research & Development, LLC | 2012-07-01 |
| A Study of Prasugrel in Healthy Participants (NCT01648790) | Eli Lilly and Company | 2012-07-01 |
| Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder (NCT01670279) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2012-07-01 |
| Interaction Between a Natural Aldehyde Dehydrogenase 2 (ALDH2) Inhibitor and Alcohol (NCT02309801) | Parc de Salut Mar | 2012-07-01 |
| Study of LY2409021 in Participants With Type 1 Diabetes (NCT01640834) | Eli Lilly and Company | 2012-07-01 |
| Trial of Eltrombopag During Consolidation Therapy in Adults With AML in Complete Remission (NCT01656252) | PrECOG, LLC. | 2012-07-01 |
| Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (NCT01652339) | Hanlim Pharm. Co., Ltd. | 2012-07-01 |
| Benzonatate Dose Tolerance Study (NCT01690975) | Pfizer | 2012-07-01 |
| Proof-of-Concept Safety Study of CPP-109 (Vigabatrin) for Treatment Refractory Tourette's Disorder (NCT01585207) | Barbara J. Coffey | 2012-07-01 |
| A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-39439335 in Healthy Japanese and Caucasian Adult Male Participants (NCT01631487) | Janssen Research & Development, LLC | 2012-07-01 |
| Comparison of Nikkomycin Z Bioavailability Under Fed and Fasting Conditions (NCT01647256) | University of Arizona | 2012-07-01 |
| PK/PD of XM22 in Children With Ewing Family of Tumors or Rhabdomyosarcoma (NCT01585649) | Merckle GmbH | 2012-07-01 |
| Clinical Safety and Preliminary Efficacy of MAGE-A4 TCR Gene-Modified T Cells to Treat Malignant Tumors (NCT01694472) | Tianjin Medical University Cancer Institute and Hospital | 2012-07-01 |
| Pharmacokinetics (PK)/Safety Study of Atorvastatin in Children With Kawasaki Disease and Coronary Artery Abnormalities (NCT01431105) | University of California, San Diego | 2012-07-01 |
| A Dose Ascending Study of Gemcitabine Elaidate (CO-101) in Combination With Cisplatin (NCT01641575) | Clovis Oncology, Inc. | 2012-07-01 |
| A Randomized, Open Label, Single Dose, 2-Way Cross-over Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Exforge® and G-0081 in Healthy Male Volunteers (NCT01776047) | Dong-A Pharmaceutical Co., Ltd. | 2012-07-01 |
| A Pharmacokinetic, Pharmacodynamic, Safety Study With AOP LDLA202, ONO LDL50 and Esmolol in Healthy Volunteers (NCT01652898) | AOP Orphan Pharmaceuticals AG | 2012-07-01 |
| Phase 1 Single Dose Escalation Study of CTB-001 (NCT01647893) | HLB Pharmaceutical Co., Ltd. | 2012-07-01 |
| A Study of LY2140023 in Healthy Participants (NCT01637142) | Denovo Biopharma LLC | 2012-07-01 |
| 99mTc-MIP-1404 for Imaging Prostate Cancer: Phase I Clinical Study to Assess the Image Quality of a Simplified Kit Formulation Compared to a Multi-step Preparation of 99mTc-MIP-1404 (NCT01654874) | Molecular Insight Pharmaceuticals, Inc. | 2012-07-01 |
| Three Times Daily Dosing of UT-15C (NCT01746485) | United Therapeutics | 2012-07-01 |
| Phase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or Stomach (NCT01611857) | SCRI Development Innovations, LLC | 2012-07-01 |
| Safety, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of Sorafenib and Eribulin in Combination (NCT01585870) | Bayer | 2012-07-01 |
| Study Of Single Ascending Doses Of PBL 1427 In Healthy Volunteers (NCT01554293) | Panacea Biotec Ltd | 2012-07-01 |
| Study to Assess Safety, Tolerability and Preliminary Efficacy of BKM120, PI3K Kinase Inhibitor, With Advanced Leukemias (NCT01396499) | M.D. Anderson Cancer Center | 2012-07-01 |
| A Study To Assess The Safety Of PF-05335810 In Hypercholesterolemic Subjects (NCT01720537) | Pfizer | 2012-07-01 |
| A Study to Assess the Effects of 2 Different Prothrombin Complex Concentrates on the Pharmacodynamics of Rivaroxaban in Healthy Adult Volunteers (NCT01656330) | Janssen Research & Development, LLC | 2012-07-01 |
| The Pharmacokinetics of LEO 90105 (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Extensive Psoriasis Vulgaris (NCT01768013) | LEO Pharma | 2012-07-01 |
| Feasibility Study of SPEEDI (NCT01889108) | Virginia Commonwealth University | 2012-07-01 |
| Exploratory Study of the Effects of Vortioxetine (Lu AA21004) on Cognition and Blood Oxygen Level Dependent (BOLD) Functional Magnetic Resonance Imaging (fMRI) Signals in Subjects Remitted From Depression and in Controls (NCT01607125) | H. Lundbeck A/S | 2012-07-01 |
| PK Study of Dapagliflozin in Pediatric Subjects With T2DM (NCT01525238) | AstraZeneca | 2012-07-01 |
| A Single-dose Phase 1 Study of DBPR108 in Healthy Male Subjects (NCT01650324) | National Health Research Institutes, Taiwan | 2012-07-01 |
| BIBF 1120 and RAD001 in Solid Tumors - Phase I (NCT01349296) | University of Cologne | 2012-07-01 |
| Effect of Testosterone Treatment on Embryo Quality (NCT01662466) | Center for Human Reproduction | 2012-07-01 |
| Autonomic Neural Regulation Therapy to Enhance Myocardial Function in Heart Failure (ANTHEM-HF) Study (NCT01823887) | Cyberonics, Inc. | 2012-07-01 |
| Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients (NCT01576406) | Pfizer | 2012-07-01 |
| Injection Laryngoplasty Using Autologous Fat Enriched With Adipose Derived Regenerative Stem Cells (ADRC) (NCT02904824) | Hospital General Universitario Gregorio Marañon | 2012-07-01 |
| Effects of Mode of Administration of Soluble Fibre Blend on Glycemia, Appetite & Sensory Parameters (NCT01657058) | Unity Health Toronto | 2012-07-01 |
| Safety, Tolerability, and PK of AN2728 in Adolescents With Atopic Dermatitis (NCT01652885) | Pfizer | 2012-07-01 |
| Dasatinib and Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumors or Other Sarcomas That Cannot Be Removed by Surgery or Are Metastatic (NCT01643278) | National Cancer Institute (NCI) | 2012-07-01 |
| Multiple Rising Dose Study of BI 144807 Powder in Bottle in Mild Asthmatic Patients (NCT01651598) | Boehringer Ingelheim | 2012-07-01 |
| Dose-finding Adaptive Phase I/IIa Study to Assess Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of IPP-204106N on Advanced Solid Tumors (NCT01711398) | Elro Pharma | 2012-07-01 |
| A Study of the Effect of Fluvoxamine on the Pharmacokinetics of RO4917523 in Healthy Volunteers (NCT01665404) | Hoffmann-La Roche | 2012-07-01 |
| A Single-Center Study of RO5508887 in Healthy Volunteers (NCT01664143) | Hoffmann-La Roche | 2012-07-01 |
| An Open-Label Study of the Effect of Bardoxolone Methyl on the Single Dose Pharmacokinetics of Digoxin and Rosuvastatin in Healthy Volunteers (NCT01598363) | Biogen | 2012-06-30 |
| Anti-CD19 White Blood Cells for Children and Young Adults With B Cell Leukemia or Lymphoma (NCT01593696) | National Cancer Institute (NCI) | 2012-06-29 |
| Aerosolized Aldesleukin in Treating Patients With Lung Metastases (NCT01590069) | M.D. Anderson Cancer Center | 2012-06-28 |
| First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Mirvetuximab Soravtansine in Adults With Ovarian Cancer and Other Folate Receptor 1 (FOLR1)-Positive Solid Tumors (NCT01609556) | ImmunoGen, Inc. | 2012-06-28 |
| Lenalidomide as Consolidation and Maintenance in Adults >/= 60 Years of Age With AML Following Standard Induction (NCT01578954) | UNC Lineberger Comprehensive Cancer Center | 2012-06-28 |
| A Multi-centre, Open Labelled, Multiple Dosing Trial Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC 0172-2021 Administered Subcutaneously to Healthy Male Subjects and Haemophilia Subjects (NCT01631942) | Novo Nordisk A/S | 2012-06-26 |
| Safety Study of a Disrupted Adenovirus (Ad) Serotype Cocaine Vaccine for Cocaine-dependent Individuals (NCT02455479) | Weill Medical College of Cornell University | 2012-06-26 |
| Autologous Stem Cell Transplantation for Crohn's Disease (NCT00692939) | Paul Szabolcs | 2012-06-26 |
| Daratumumab in Combination With Lenalidomide and Dexamethasone in Relapsed and Relapsed-refractory Multiple Myeloma (NCT01615029) | Janssen Research & Development, LLC | 2012-06-26 |
| A Study Evaluating the Effect of a Single-dose Oral Administration of Nemonoxacin Capsule on QTc Intervals and Heart Rhythms of Healthy Subjects and the Influence of Food Intake on QTc Intervals and Pharmacokinetic Characteristics (NCT03362853) | TaiGen Biotechnology Co., Ltd. | 2012-06-25 |
| Pazopanib in Combination With PCI-24781 in Patients With Metastatic Solid Tumors (NCT01543763) | Pamela Munster | 2012-06-25 |
| A Study Comparing the Pharmacokinetic and Pharmacodynamic Profiles for Sitagliptin, Saxagliptin and Vildagliptin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-142) (NCT01582308) | Merck Sharp & Dohme LLC | 2012-06-21 |
| Everolimus and Anakinra or Denosumab in Treating Participants With Relapsed or Refractory Advanced Cancers (NCT01624766) | M.D. Anderson Cancer Center | 2012-06-19 |
| Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor Cancer (NCT01607905) | Karyopharm Therapeutics Inc | 2012-06-18 |
| A Study of Selumetinib in Patients With Kaposi's Sarcoma (NCT01752569) | Sheffield Teaching Hospitals NHS Foundation Trust | 2012-06-15 |
| A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Adult Participants With Advanced or Refractory Solid Tumors or Lymphoma (NCT01703481) | Janssen Research & Development, LLC | 2012-06-15 |
| A Study Combining Ibrutinib With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With CD20-Positive B-Cell Non Hodgkin Lymphoma (NCT01569750) | Janssen Research & Development, LLC | 2012-06-14 |
| Phase 1 Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Solid Tumors (NCT01765790) | Baxalta now part of Shire | 2012-06-14 |
| Sirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery (NCT01791088) | University of Chicago | 2012-06-13 |
| An Open-Label, Phase I/II Study of Two Different Schedules of Dasatinib (Sprycel) and Decitabine (Dacogen) Used in Combination for Patients With Accelerated or Blastic Phase Chronic Myelogenous Leukemia (Protocol CA180357) (NCT01498445) | M.D. Anderson Cancer Center | 2012-06-12 |
| Ipilimumab and Gemcitabine Hydrochloride in Treating Patients With Stage III-IV or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery (NCT01473940) | Northwestern University | 2012-06-11 |
| Carboplatin in Treating Patients With Recurrent High-Grade Gliomas (NCT01644955) | James Elder | 2012-06-11 |
| Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative Neoplasms (NCT01520220) | Eli Lilly and Company | 2012-06-11 |
| A Trial Investigating the Pharmacodynamic Properties of NN1218 in Subjects With Type 1 Diabetes (NCT01618188) | Novo Nordisk A/S | 2012-06-11 |
| BKM120 Combined With Vemurafenib (PLX4032) in BRAFV600E/K Mutant Advanced Melanoma (NCT01512251) | University of California, San Francisco | 2012-06-09 |
| Azacitidine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With High-Risk Acute Myeloid Leukemia (NCT01839240) | University of Chicago | 2012-06-06 |
| Clofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia (NCT01629082) | National Heart, Lung, and Blood Institute (NHLBI) | 2012-06-06 |
| A Study of MLN9708 in Japanese Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM) (NCT04272775) | Takeda | 2012-06-05 |
| First Human Dose Trial of NNC0215-0384 in Subjects With Rheumatoid Arthritis (NCT01611688) | Novo Nordisk A/S | 2012-06-04 |
| Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Repeat IV Doses (NCT01615796) | GlaxoSmithKline | 2012-06-04 |
| Safety Study of AMG 557 in Subjects With Lupus Arthritis (NCT01683695) | Amgen | 2012-06-01 |
| A Phase I, Dose-finding Study of BEZ235 in Adult Patients With Relapsed or Refractory Acute Leukemia (NCT01756118) | Goethe University | 2012-06-01 |
| Immunomodulatory Effects of Silymarin in Patients With Beta-Thalassemia Major (NCT01752153) | Shiraz University of Medical Sciences | 2012-06-01 |